Ledger.Open graph →

SEC Form D · Amendment · filed May 5, 2020

Phylos Bioscience, Inc

Offering

$26.0M

Sold

$12.2M

Exemption

Rule 506(c)

Industry

Other

Location

PORTLAND, OR

Type

—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (18)

Ralph J. Risch · Portland, ORExec Mowgli Holmes · Portland, ORExec · Director Nishan Karassik · Portland, ORExec · Director Lada J. Rasochova, Phd · Portland, ORDirector Scott J. Bowman · Portland, ORExec Timothy J. Gregory · Portland, ORDirector Daniella Kranjac · Englewood Cliffs, NJDirector David M. Mccoy · CHICAGO, ILExec Michael D. Feinglass · CHICAGO, ILExec · Director Andrew D. Cooper · Phoenix, AZDirector Mario M. Kranjac · Englewood Cliffs, NJExec · Director Nell M. Blatherwick · CHICAGO, ILExec Stanton T. Marcum · Sanibel, FLExec · Director Andrea T. Johnson · Florence, KYExec Vehano Joseph · Tampa, FLExec Matthew Morgan · Boston, MADirector Peter Ballantyne · Houston, TXExec · Director Ryan Droege · Atlanta, GADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗